Opinion: STAT+: The NIH budget should be $100 billion per year
In late August, the Food and Drug Administration approved a new therapeutic for pancreatic cancer, daraxonrasib, developed by Revolution Medicines. This drug is for previously treated patients and represents a revolutionary new therapeutic to…
ImpactMinor 12/100
Why it mattersRule-based estimate: event keywords (+6), soft/evergreen signals; trust 8/10.
RegionsGlobal
Published3 h ago (Mon, 21 Sep 2026 08:30:00 GMT)
RetrievedMon, 21 Sep 2026 09:00:46 GMT via rss
ClassifiedMon, 21 Sep 2026 09:00:51 GMT by heuristic
AuthorReed Jobs